Skip to content
Government Federal, Medical Health Aged Care

Delving into diabetes

House of Representatives 2 mins read

The broader impacts of diabetes on Australia’s health system and economy, and recent advances in the prevention and management of this significant health condition, will be the focus of a new inquiry by the House Health Committee.

The Chair of the Committee, Dr Mike Freelander MP, stated: ‘Diabetes is the world’s fastest growing chronic health condition, currently impacting approximately 1.3 million Australians. There are multiple forms of diabetes, including type 1, type 2, gestational and other rare types. The Committee looks forward to conducting this inquiry to better understand the current situation regarding diabetes in Australia, including the effectiveness of current Australian Government policies and programs aiming to prevent, diagnose and manage the condition.’

‘The Inquiry will be broad and will also look at lifestyle factors and the interaction between lifestyle, Type 2 diabetes, and obesity’ stated Dr Freelander.

‘The Committee looks forward to hearing from individuals with diabetes, healthcare service providers, researchers, peak bodies, the Australian Government, state and territory governments and members of the public to understand new evidence-based advances in the prevention and management of the condition, and the broader impacts of diabetes on Australia’s health system and economy’ he said.

Submissions from interested individuals and organisations are invited by 31 August 2023. The preferred method of receiving submissions is by electronic format lodged online using a My Parliament account.

Further information about the Committee’s inquiry, including the full terms of reference and details on how to lodge a submission are available at the Committee’s website.

****Media call, 11.30am, Senate Courtyard****

Members of the House of Representatives Standing Committee on Health, Aged Care and Sport will be available at 11.30am today (30 May 2023) to speak about and answer questions on the inquiry.

Media inquiries

Dr Mike Freelander MP
Chair of the House of Representatives Standing Committee on Health, Aged Care and Sport
Mike.Freelander.MP@aph.gov.au
(02) 4620 0293

For background information

Committee Secretariat
02 6277 4145
Health.Reps@aph.gov.au

 



More from this category

  • Federal Budget, Government Federal
  • 01/01/2025
  • 08:58
ACOSS

Today’s indexation fails to meet needs amid escalating crisis

The Federal Government must urgently lift income support payments as cost of living pressures are expected to take centre stage in the next budget and 2025 federal election. Today’s routine indexation of income support payments is grossly inadequate, leaving millions unable to afford basic essentials. Youth Allowance for a single person living away from home is only going up by $1.70 a day. This lifts Youth Allowance and Austudy to a mere $47 a day, which is 36% of the minimum wage. Some income support payments including Youth Allowance and Austudy are adjusted for inflation on January 1 each year.…

  • Federal Budget, Government Federal
  • 01/01/2025
  • 07:00
ACOSS

Today’s indexation fails to meet needs amid escalating crisis

The Federal Government must urgently lift income support payments as cost of living pressures are expected to take centre stage in the next budget and 2025 federal election. Today’s routine indexation of income support payments is grossly inadequate, leaving millions unable to afford basic essentials. Youth Allowance for a single person living away from home is only going up by $1.70 a day. This lifts Youth Allowance and Austudy to a mere $47 a day, which is 36% of the minimum wage. Some income support payments including Youth Allowance and Austudy are adjusted for inflation on January 1 each year.…

  • Medical Health Aged Care
  • 27/12/2024
  • 17:11
Takeda Pharmaceutical Company Limited

Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia

HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] is the First and Only Facilitated Subcutaneous Immunoglobulin (fSCIG) Approved in Japan for Agammaglobulinemia…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.